For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the...

A Blueprint for FDA: Recommendations to Improve Innovation and Access [1] (FDA Blueprint) is a timely white paper authored by University...

The National Institutes of Health (NIH) recently announced the launch of a major artificial intelligence (AI) initiative aimed at...

Immunotherapies have provided successful precision therapy for human diseases by reducing side effects caused by untargeted...

Personalized medicine relies on accurate and clinically relevant diagnostic tests for effective disease treatment. Traditional genetic...

Between 2014-2023, China has filed more patent applications (38,000) covering Generative AI (GenAI) technology than another other...

GenAI, or Generative AI, has seen a surge in patenting activity with China leading the way in filing patent applications for this...

Sarepta's recent announcement of the U.S. Food and Drug Administration's approval for ELEVIDYS to treat Duchenne patients aged 4 and...